Health-related quality of life after transcatheter aortic valve replacement in inoperable patients with severe aortic stenosis

Circulation

Volumn 124, Issue 18, 2011, Pages 1964-1972

  Reynolds, Matthew R ^a   Magnuson, Elizabeth A ^k   Lei, Yang ^k   Leon, Martin B ^b   Smith, Craig R ^b   Svensson, Lars G ^c   Webb, John G ^d   Babaliaros, Vasilis C ^e   Bowers, Bruce S ^j   Fearon, William F ^f   Herrmann, Howard C ^g   Kapadia, Samir ^c   Kodali, Susheel K ^b   Makkar, Raj R ^h   Pichard, Augusto D ⁱ   Cohen, David J ^j,k  

^a HARVARD CLINICAL RESEARCH INSTITUTE   (United States)

^b New York Presbyterian Hospital Columbia University Medical Center   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

^d ST PAUL S HOSPITAL   (Canada)

^e EMORY UNIVERSITY HOSPITAL   (United States)

^f Medical City Dallas ^*  (United States)

^g STANFORD UNIVERSITY   (United States)

^h UNIVERSITY OF PENNSYLVANIA   (United States)

ⁱ CEDARS SINAI MEDICAL CENTER   (United States)

^j WASHINGTON HOSPITAL CENTER   (United States)

^k UNIVERSITY OF MISSOURI KANSAS CITY SCHOOL OF MEDICINE   (United States)

more..

Author keywords

aortic valve stenosis; heart valves; quality of life

Indexed keywords

AGED; AORTA STENOSIS; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; KANSAS CITY CARDIOMYOPATHY QUESTIONNAIRE; MAJOR CLINICAL STUDY; MALE; PATIENT CARE; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SHORT FORM 12; SYMPTOM; TRANSCATHETER AORTIC VALVE IMPLANTATION; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; AORTIC VALVE STENOSIS; CARDIAC CATHETERIZATION; FEMALE; FOLLOW-UP STUDIES; HEALTH STATUS; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; MALE; PROSPECTIVE STUDIES; QUALITY OF LIFE; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX;

EID: 80255135508     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.111.040022     Document Type: Article

References (33)

1. Ross J, Braunwald E. Aortic stenosis. Circulation. 1968;38:61-67.
2. Davies SW, Gershlick AH, Balcon R. Progression of valvular aortic stenosis: a long-term retrospective study. Eur Heart J. 1991;12:10-14.
3. Sundt TM, Bailey MS, Moon MR, Mendeloff EN, Huddleston CB, Pasque MK, Barner HB, Gay WA Jr. Quality of life after aortic valve replacement at the age of >80 years. Circulation. 2000;102(suppl):III-70-III-74.
4. Schwarz F, Baumann P, Manthey J, Hoffmann M, Schuler G, Mehmel HC, Schmitz W, Kubler W. The effect of aortic valve replacement on survival. Circulation. 1982;66:1105-1110. (Pubitemid 12036848)
5. Bach DS, Siao D, Girard SE, Duvernoy C, McCallister BD Jr, Gualano SK. Evaluation of patients with severe symptomatic aortic stenosis who do not undergo aortic valve replacement: the potential role of subjectively overestimated operative risk. Circ Cardiovasc Qual Outcomes. 2009;2: 533-539.
6. Iung B, Cachier A, Baron G, Messika-Zeitoun D, Delahaye F, Tornos P, Gohlke-Barwolf C, Boersma E, Ravaud P, Vahanian A. Decision-making in elderly patients with severe aortic stenosis: why are so many denied surgery? Eur Heart J. 2005;26:2714-2720. (Pubitemid 41746694)
7. Ben-Dor I, Pichard AD, Gonzalez MA, Weissman G, Li Y, Goldstein SA, Okubagzi P, Syed AI, Maluenda G, Collins SD, Delhaye C, Wakabayashi K, Gaglia MA Jr, Torguson R, Xue Z, Satler LF, Suddath WO, Kent KM, Lindsay J, Waksman R. Correlates and causes of death in patients with severe symptomatic aortic stenosis who are not eligible to participate in a clinical trial of transcatheter aortic valve implantation. Circulation. 2010;122:S37-S42.
8. Leon MB, Smith CR, Mack M, Miller DC, Moses JW, Svensson LG, Tuzcu EM, Webb JG, Fontana GP, Makkar RR, Brown DL, Block PC, Guyton RA, Pichard AD, Bavaria JE, Herrmann HC, Douglas PS, Petersen JL, Akin JJ, Anderson WN, Wang D, Pocock S. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010;363:1597-1607.
9. Cribier A, Eltchaninoff H, Bash A, Borenstein N, Tron C, Bauer F, Derumeaux G, Anselme F, Laborde F, Leon MB. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation. 2002;106:3006-3008. (Pubitemid 35440280)
10. Thomas M, Schymik G, Walther T, Himbert D, Lefevre T, Treede H, Eggebrecht H, Rubino P, Michev I, Lange R, Anderson WN, Wendler O. Thirty-day results of the Sapien aortic bioprosthesis European outcome (SOURCE) registry: a European registry of transcatheter aortic valve implantation using the Edwards Sapien valve. Circulation. 2010;122: 62-69.
11. Rodes-Cabau J, Webb JG, Cheung A, Ye J, Dumont E, Feindel CM, Osten M, Natarajan MK, Velianou JL, Martucci G, DeVarennes B, Chisholm R, Peterson MD, Lichtenstein SV, Nietlispach F, Doyle D, DeLarochelliere R, Teoh K, Chu V, Dancea A, Lachapelle K, Cheema A, Latter D, Horlick E. Transcatheter aortic valve implantation for the treatment of severe symptomatic aortic stenosis in patients at very high or prohibitive surgical risk: acute and late outcomes of the multicenter Canadian experience. J Am Coll Cardiol. 2010;55:1080-1090.
12. Gurvitch R, Wood DA, Tay EL, Leipsic J, Ye J, Lichtenstein SV, Thompson CR, Carere RG, Wijesinghe N, Nietlispach F, Boone RH, Lauck S, Cheung A, Webb JG. Transcatheter aortic valve implantation: durability of clinical and hemodynamic outcomes beyond 3 years in a large patient cohort. Circulation. 2010;122:1319-1327.
13. Lewis EF, Johnson PA, Johnson W, Collins C, Griffin L, Stevenson LW. Preferences for quality of life or survival expressed by patients with heart failure. J Heart Lung Transplant. 2001;20:1016-1024. (Pubitemid 32824149)
14. Lazar HL. Transcatheter aortic valves: where do we go from here? N Engl J Med. 2010;363:1667-1668.
15. Spertus JA, Tooley J, Jones P, et al. Expanding the outcomes in clinical trials of heart failure: the quality of life and economic components of the EPHESUS (EPlerenone's neuroHormonal Efficacy and Survival Study). Am Heart J. 2002;143:636-642. (Pubitemid 34454696)
16. Green CP, Porter CB, Bresnahan DR, Spertus JA. Development and evaluation of the Kansas City Cardiomyopathy Questionnaire: a new health status measure for heart failure. J Am Coll Cardiol. 2000;35: 1245-1255. (Pubitemid 30206900)
17. Spertus J, Peterson E, Conard MW, Heidenreich PA, Krumholz HM, Jones P, McCullough PA, Pina I, Tooley J, Weintraub WS, Rumsfeld JS. Monitoring clinical changes in patients with heart failure: a comparison of methods. Am Heart J. 2005;150:707-715. (Pubitemid 41396503)
18. Soto GE, Jones P, Weintraub WS, Krumholz HM, Spertus JA. Prognostic value of health status in patients with heart failure after acute myocardial infarction. Circulation. 2004;110:546-551. (Pubitemid 39031171)
19. Chan PS, Soto G, Jones PG, Nallamothu BK, Zhang Z, Weintraub WS, Spertus JA. Patient health status and costs in heart failure: insights from the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS). Circulation. 2009;119:398-407.
20. Ware J, Kosinski M, Keller SD. A 12-item short-form health survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996;34:220-233. (Pubitemid 126433231)
21. Wyrwich KW, Spertus JA, Kroenke K, Tierney WM, Babu AN, Wolinsky FD. Clinically important differences in health status for patients with heart disease: an expert consensus panel report. Am Heart J. 2004; 147:615-622. (Pubitemid 38900445)
22. Ware J, Kosinski M, Bjorner JB, Turner-Bowker DM, Gandek B, Maruish ME. Determining important differences in scores. User's Manual for the SF-36v2 Health Survey. Lincoln, RI: Quality Metric Inc; 2007.
23. Ware JE Jr, Kosinski M, Turner-Bowker DM, Gandek B. How to Score Version 2 of the SF-12 Health Survey (With a Supplement Documenting Version 1). Lincoln, RI: Quality Metric Incorporated; 2002.
24. Jennrich RI, Schluchter MD. Unbalanced repeated-measures models with structured covariance matrices. Biometrics. 1986;42:805-820. (Pubitemid 17134900)
25. Rubin DB. Inference and missing data. Biometrika. 1976;63:581-592.
26. Shroyer AL, Coombs LP, Peterson ED, Eiken MC, DeLong ER, Chen A, Ferguson TB Jr, Grover FL, Edwards FH; Society of Thoracic Surgeons. The Society of Thoracic Surgeons: 30-day operative mortality and morbidity risk models. Ann Thorac Surg. 2003;75:1856-1864.
27. Dodek A, Hooper RO, Kiess M. Percutaneous balloon valvuloplasty for aortic stenosis: improved quality of life for elderly patients. Can J Cardiol. 1988;4:223-227.
28. Feldman T. Proceedings of the TCT: balloon aortic valvuloplasty appropriate for elderly valve patients. J Interv Cardiol. 2006;19:276-279. (Pubitemid 43823317)
29. Khan JH, McElhinney DB, Hall TS, Merrick SH. Cardiac valve surgery in octogenarians: improving quality of life and functional status. Arch Surg. 1998;133:887-893. (Pubitemid 28374284)
30. Gotzmann M, Hehen T, Germing A, Lindstaedt M, Yazar A, Laczkovics A, Mumme A, Mugge A, Bojara W. Short-term effects of transcatheter aortic valve implantation on neurohormonal activation, quality of life and 6-minute walk test in severe and symptomatic aortic stenosis. Heart. 2010;96:1102-1106.
31. Bekeredjian R, Krumsdorf U, Chorianopoulos E, Kallenbach K, Karck M, Katus HA, Rottbauer W. Usefulness of percutaneous aortic valve implantation to improve quality of life in patients >80 years of age. Am J Cardiol. 2010;106:1777-1781.
32. Ussia GP, Mule M, Barbanti M, Cammalleri V, Scarabelli M, Imme S, Capodanno D, Ciriminna S, Tamburino C. Quality of life assessment after percutaneous aortic valve implantation. Eur Heart J. 2009;30: 1790-1796.
33. Svensson LG, Dewey T, Kapadia S, Roselli EE, Stewart A, Williams M, Anderson WN, Brown D, Leon M, Lytle B, Moses J, Mack M, Tuzcu M, Smith C. United States feasibility study of transcatheter insertion of a stented aortic valve by the left ventricular apex. Ann Thorac Surg. 2008;86:46-54.